SCHEMBL15890992

SCHEMBL15890992

CC/C(=C\c1cccc(F)c1)C(=O)O

nearest known ligand 0.59

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 1/20 0.53
▸ PTGS1 P23219 3/20 0.52
▸ AKR1C3 P42330 1/20 0.50
▸ EPHX2 P34913 2/20 0.49
▸ AKR1C2 P52895 1/20 0.49
▸ FBP1 P09467 1/20 0.45
▸ NFE2L2 Q16236 2/20 0.44
▸ PTGS2 P35354 2/20 0.44
▸ TBXAS1 P24557 2/20 0.44
▸ CYP3A4 P08684 2/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ PPARG P37231 2/20 0.42
▸ CYP1A2 P05177 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ PKM P14618 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ THPO P40225 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15890993 1.00 MAPT (0.53) MAPTPTGS1AKR1C3EPHX2AKR1C2
SCHEMBL31293405 0.84 RECQL (0.50) MAPTPTGS1AKR1C3AKR1C2FBP1
SCHEMBL1655140 0.84 RECQL (0.50) MAPTPTGS1AKR1C3AKR1C2FBP1
SCHEMBL1655139 0.84 RECQL (0.50) MAPTPTGS1AKR1C3AKR1C2FBP1
SCHEMBL1579813 0.82 TBXAS1 (0.48) AKR1C3EPHX2TBXAS1CYP3A4CYP2C9
SCHEMBL14032639 0.82 EPHX2 (0.47) MAPTPTGS1EPHX2FBP1PTGS2
SCHEMBL6338925 0.82 KDM4E (0.58) EPHX2TBXAS1CYP3A4CYP2C9
SCHEMBL20184163 0.82 KDM4E (0.58) EPHX2TBXAS1CYP3A4CYP2C9
SCHEMBL2391183 0.82 KDM4E (0.58) EPHX2TBXAS1CYP3A4CYP2C9
SCHEMBL1579814 0.82 TBXAS1 (0.48) AKR1C3EPHX2TBXAS1CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8791119-B2 3,4-dihydropyrrolo[1,2-A]pyrazine-2,8(1H)-dicarboxamide derivatives, preparation thereof and therapeutic use thereof for diseases involving casein kinase 1 epsilon and/or casein kinase 1 delta SANOFI (FR) 2014-07-29 — — US disclosed
Send feedback